American College of Cardiology
Avatar

TWILIGHT-HBR: Ticagrelor Monotherapy in HBR Patients Undergoing PCI

By American College of Cardiology FEATURING Valentin Fuster, Dipti Itchhaporia
February 15, 2022
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
08:43
Scottsdale Interventional Forum 2013

Debate: We Have Enough Information to Cut DAPT Down to 6 Months for …

Feat. D. Rizik
08:25
Scottsdale Interventional Forum 2013

Debate: We Still Need More Data Before Cutting the Duration of DAPT …

Feat. J. Hermiller
22:08
Scottsdale Interventional Forum 2013

Antithrombotic Pharmacology in ACS PCI: What’s Practical, What’s in …

Feat. R. Harrington
17:19
Scottsdale Interventional Forum 2014

Essentials of ACS/PCI Pharmacology: An Overview and Approach

Feat. R. Harrington
14:49
Scottsdale Interventional Forum 2014

The Big Ten: Pivotal Coronary Trials of the Last Year

Feat. M. Parikh
41:22
Scottsdale Interventional Forum 2014

Friday Lunch - Conversations in Cardiology Featuring Morton J Kern

Feat. M. Kern
16:55
Scottsdale Interventional Forum 2015

PCI Pharmacology in 2015: Choosing the Right Antiplatelet & Anti…

Feat. S. Bailey
14:17
Scottsdale Interventional Forum 2015

Beyond ISAR Triple: Optimal Triple Drug Therapy After DES Implantati…

Feat. M. Kutcher
21:27
ARCH Advanced Revascularization Symposium

Acute Coronary Syndromes

Feat. R. Bach
19:24
San Diego Cardiovascular Interventions 2015

Contemporary Antithrombin and Antiplatelet Therapy for PCI

Feat. W. Penny
22:38
Complex Interventional Cardiovascular Therapy (CICT) 2015

DAPT after coronary stenting should be extended beyond 12 months

Feat. J. Messenger
20:25
Complex Interventional Cardiovascular Therapy (CICT) 2015

DAPT after coronary stenting should be limited to 6 months

13:15
Complex Cardiovascular Catheter Therapeutics (C3)

Pathophysiological Insights into Acute Coronary Syndrome by Optical …

Feat. Y. Murasato
12:03
Complex Cardiovascular Catheter Therapeutics (C3)

What are the Major Pharmacodynamic and Safety Differences Between An…

Feat. S. Nathan
12:55
Scottsdale Interventional Forum 2016

Update on PCI Pharmacology: What the Interventionalist needs to know…

Feat. S. Bailey
40:18
ARCH Advanced Revascularization Symposium

Top Trials in Interventional Cardiology in 2015-2016

Feat. J. Popma
15:31
ARCH Advanced Revascularization Symposium

Acute Coronary Syndrome Update

Feat. R. Bach
21:52
Complex Coronary Valvular and Vascular Cases Conference

Optimal Duration of DAPT: Update on DAPT Guidelines

Feat. R. Mehran
10:12
Complex Coronary Valvular and Vascular Cases Conference

Anti-Thrombotic Therapy for PCI

Feat. D. Bhatt
10:42
Complex Coronary Valvular and Vascular Cases Conference

Timing of DAPT Interruption and DES Thrombosis